Holen Sie sich die Stockscreener-App
1.8928
5.80%
0.0828
Mindwalk Holdings Corp Aktie (HYFT) Neueste Nachrichten
MindWalk (HYFT) Announces Share Repurchase Plan - GuruFocus
MindWalk Holdings (HYFT) Announces 2.3M Share Buyback Program - GuruFocus
MindWalk Holdings Corp. authorizes a Buyback Plan. - MarketScreener
MindWalk Holdings Corp. announces an Equity Buyback for 2,300,000 shares. - MarketScreener
MindWalk Holdings announces 2.3M share buyback program - MSN
MindWalk announces $2.3 million share repurchase program By Investing.com - Investing.com Nigeria
MindWalk Holdings Initiates Share Repurchase Program to Enhance Shareholder Value - TipRanks
MindWalk announces $2.3 million share repurchase program - Investing.com India
MindWalk Announces Share Repurchase Program - The Joplin Globe
MindWalk Unveils Dual-Pathway Regimen in Longevity Therapeutics - MSN
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand - Insider Monkey
MindWalk expands GLP-1 program with AI-discovered longevity pathway By Investing.com - Investing.com Nigeria
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - The AI Journal
Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform (09/22/2025 00:00 - MarketScreener
MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement By Investing.com - Investing.com South Africa
MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement - Investing.com
MindWalk (HYFT) Unveils Breakthrough in GLP-1 Therapeutic Progra - GuruFocus
MindWalk expands GLP-1 program with AI-discovered longevity pathway - Investing.com
MindWalk advances AI-designed GLP-1 program with first-in-class dual-pathway regimen for aging and longevity - MarketScreener
MindWalk : Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform - MarketScreener
How MindWalk Holdings' Rebranding and Improved Earnings May Impact HYFT Investors - Yahoo Finance
MindWalk Holdings Reports Strong Revenue Growth and Improved Margins - TipRanks
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Rebranding - GuruFocus
MindWalk Holdings Reports Q3 2025 Financial Results and Strategic Growth - TipRanks
MindWalk Holdings Corp reports results for the quarter ended July 31Earnings Summary - TradingView
MindWalk Holdings Corp. Reports Earnings Results for the First Quarter Ended July 31, 2025 - MarketScreener
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly - PharmiWeb.com
Earnings call transcript: MindWalk Inc. reports strong Q1 2025 performance, rebrands from ImmunoPrecise Antibodies - Investing.com UK
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet - Business Wire
MindWalk Holdings Reports Record Revenue and Strategic Divestiture - TipRanks
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet | FinancialContent - FinancialContent
MindWalk : 2025 Combined Financial Statements - MarketScreener
MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025 - Business Wire
MindWalk Holdings Corp.HYFTStock Price Today - Zacks Investment Research
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT By Investing.com - Investing.com Canada
HYFT's Rebranding: A Strategic Pivot in Biotech's AI-Driven Future - AInvest
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT - Investing.com
Immunoprecise rebrands as Mindwalk, announces Nasdaq ticker change to "HYFT" - MarketScreener
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - FinancialContent
Leading Biotech ImmunoPrecise Antibodies Joins Major H.C. Wainwright Investment Conference in New York - Stock Titan
AI-Powered Universal Dengue Vaccine Breakthrough: ImmunoPrecise's LENSai Platform Advances to Animal Studies - Stock Titan
Strategic Acquisition: AVS Bio Expands Global Biologics Reach with ImmunoPrecise Europe Buyout - Stock Titan
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA - Business Wire
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):